Tufts Lyme Disease Initiative receives $7M in grants to advance research to next level

Researchers at the Tufts Lyme Disease Initiative recently received grants totaling more than $7 million to build on an already impressive array of discoveries that Tufts’ teams have made to combat tick-borne diseases.

Sorrento plans stock sale to raise $105m to recover from bankruptcy – Pharmaceutical Technology

Sorrento ended up with a ruling awarding $156.8m and $17m to NantCell and NANTibody, respectively in December 2022. Image Credit: GussWilder / Getty Images. Sorrento

August 9, 2023

Maternal Mortality Remains ‘Unacceptably High’ in the U.S., Study Shows

Maternal mortality remains “unacceptably high” among all racial and ethnic groups in the U.S., but certain groups are at even more of an increased risk,

July 6, 2023

atai Life Sciences Reports First Quarter 2024 Financial Results and Corporate Updates | Psychedelic Invest

NEW YORK and BERLIN, May 15, 2024 (GLOBE NEWSWIRE) — atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of

May 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.